Flu News and Research

RSS

Newly identified antibodies could lead to better treatments and vaccines for influenza

A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.

25 Oct 2019

Researchers find antibody that may protect against wide range of lethal influenza viruses

A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.

25 Oct 2019

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

An analysis and related commentary published in Clinical Infectious Diseases today provide in-depth examination of the deplorable and dangerous conditions in U.S. immigrant detention centers where seven children have died in the last 10 months.

25 Oct 2019

UAB physicians encourage everyone to get a flu shot between October and early November

The change of season in October and November brings in crisp, fall weather for the majority of the United States. Many begin to look toward the holiday season to come, but few think about the impending cold weather and subsequent sickness that pops up when winter arrives.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Emory researchers awarded NIAID contract to develop better drug against influenza

With the flu killing an average of 20,000 people annually in the United States and posing the larger threat of global pandemics, Emory University's strides in influenza research carry the hope of saving lives here and abroad.

23 Oct 2019

Los Alamos' predictive AI computer model wins FluSight Challenge

A probabilistic artificial intelligence computer model developed at Los Alamos National Laboratory provided the most accurate state, national, and regional forecasts of the flu in 2018, beating 23 other teams in the Centers for Disease Control and Prevention's FluSight Challenge. The CDC announced the results last week.

22 Oct 2019

Antibiotic resistance doubles in just two decades

Antibiotic resistance poses a grave challenge to many previously curable infectious diseases. At present, antibiotic resistance is proving to increase at a much faster rate compared to the development of new therapies.

21 Oct 2019

Ebola virus vaccine still effective against the infection even in low concentrations

The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.

21 Oct 2019

Patients with diabetes may have worse lung infections

People with diabetes are at a higher risk of various complications, including worse respiratory diseases. One of the most dreaded lung diseases is the Middle East respiratory syndrome coronavirus (MERS-CoV), which emerged in Saudi Arabia in 2012.

21 Oct 2019

Neutrophil extracellular traps could cause organ damage in malaria

Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure.

21 Oct 2019

Novel approach brings researchers one step closer to universal flu vaccine

The scourge of the influenza virus devastates health and claims many lives worldwide each year. It is especially daunting because vaccines are only protective when they are well matched to the strains circulating in the population.

18 Oct 2019

Study finds little evidence of 'immigrant health paradox' among Arab Americans

First generation immigrants to the United States from Latin America, South America, and Asia have been shown to have better health outcomes and behaviors than second generation (born in the U.S. to immigrant parents) and third generation (born in the U.S. to U.S.-born parents with immigrant heritage) immigrants -- a phenomenon known as the "immigrant health paradox."

17 Oct 2019

Tips to help strengthen your defenses this flu season

Flu season can take its toll on your health, but one way to fight the virus is to stop the spread of germs at home.

17 Oct 2019

Spectrum Health, MSU researchers aim to find new or better treatments for "orphan diseases"

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs.

16 Oct 2019

Flu test: Is it needed?

Flu season is fast approaching. When flu symptoms strike, you may wonder if you or your loved ones should get a flu test before beginning treatment.

15 Oct 2019

Get vaccinated to protect yourself from flu, say Johns Hopkins experts

Cases of the flu are already on the rise around the nation as flu season begins. Johns Hopkins Medicine experts say now is the time to fight against the flu as the number of people getting sick from the potentially life-threatening virus will increase in the coming months.

14 Oct 2019

CRISPR RNA-cutting enzyme programmed to destroy viruses in human cells

Many of the world's most common or deadly human pathogens are RNA-based viruses -- Ebola, Zika and flu, for example -- and most have no FDA-approved treatments.

10 Oct 2019

Hand sanitizers are effective, but nothing can beat traditional handwashing

Whether they dangle from keychains, spritz from pens or froth and pump out of clinic and classroom dispensers, hand sanitizers are convenient alternatives to handwashing, and they do work.

9 Oct 2019

Flu News and Research

Newly identified antibodies could lead to better treatments and vaccines for influenza

Researchers find antibody that may protect against wide range of lethal influenza viruses

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

UAB physicians encourage everyone to get a flu shot between October and early November

Flu antibody could be a key to better treatments for severe flu disease

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

Emory researchers awarded NIAID contract to develop better drug against influenza

Los Alamos' predictive AI computer model wins FluSight Challenge

Antibiotic resistance doubles in just two decades

Ebola virus vaccine still effective against the infection even in low concentrations

Patients with diabetes may have worse lung infections

Neutrophil extracellular traps could cause organ damage in malaria

Novel approach brings researchers one step closer to universal flu vaccine

Study finds little evidence of 'immigrant health paradox' among Arab Americans

Tips to help strengthen your defenses this flu season

Spectrum Health, MSU researchers aim to find new or better treatments for "orphan diseases"

Flu test: Is it needed?

Get vaccinated to protect yourself from flu, say Johns Hopkins experts

CRISPR RNA-cutting enzyme programmed to destroy viruses in human cells

Hand sanitizers are effective, but nothing can beat traditional handwashing

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News